Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.5% of adults in Reno have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Census population 264,165. Nevada Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Reno clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Reno storefront.
Wharton's Jelly Allograft Products in Reno, NV for clinics & physicians. Wharton's jelly allografts rich i… Compliance support & pricing — contact Hawk Medical.
Copy-pasting a First Coast (Florida) LCD into a Nevada chart is a denial pattern. You are JE. CDC PLACES (2023, crude) estimates 9.5% of adults in Reno have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Use Nevada Division of Public and Behavioral Health for community education; use the IFU for the product in the fridge. whartons jelly allograft is the SKU conversation, not a patient appointment book.
National Wharton's Jelly Allograft Products notes (how the product actually works)13% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 250k–500k with 264,165 residents will still mix those payers. CDC PLACES (2023, crude) estimates 9.5% of adults in Reno have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Reno trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 9.5% of adults in Reno have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 9.5% of adults — 2.5 points below the U.S. 12% figure. Obesity is 28.4%; arthritis is 23.7%. That is place-level BRFSS modeling, not a clinic census and not a Reno trial.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Reno.
It is the Census city-proper count — useful as scale for a city of 250k–500k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
Nevada is JE. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
Bring specialty, monthly joint / regenerative volume, and whether you bill JE FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 9.5% diabetes and 23.7% arthritis for Reno — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Reno, NV.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Reno is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Reno — 2.5 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Nevada Part B wound biologics follow this contractor (siblings: CA, HI). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Reno. Useful for joint-program math; still needs a diagnosis and privileging.
No Reno storefront. Joe Bradley is an active practice owner. whartons jelly allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.